التفاصيل البيبلوغرافية
| العنوان: |
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study -- United States, August 19, 2022-March 31, 2023. |
| المؤلفون: |
Dalton, Alexandra F., Diallo, Alpha Oumar, Chard, Anna N., Moulia, Danielle L., Deputy, Nicholas P., Fothergill, Amy, Kracalik, Ian, Wegner, Christopher W., Markus, Tiffanie M., Pathela, Preeti, Still, William L., Hawkins, Sam, Mangla, Anil T., Ravi, Nivedita, Licherdell, Erin, Britton, Amber, Lynfield, Ruth, Sutton, Melissa, Hansen, AmberJean P., Betancourt, Gabriela S. |
| المصدر: |
MMWR: Morbidity & Mortality Weekly Report; 5/19/2023, Vol. 72 Issue 20, p553-558, 6p, 3 Charts |
| مصطلحات موضوعية: |
VACCINES, MONKEYPOX, TRANSGENDER people, SMALLPOX |
| الشركة/الكيان: |
UNITED States. Food & Drug Administration |
| مستخلص: |
The article discusses the effectiveness of the JYNNEOS vaccine in preventing monkeypox (mpox) among gay, bisexual, and other men who have sex with men (MSM) and transgender individuals. Topics discussed include the approval of the JYNNEOS vaccine by the Food and Drug Administration (FDA) for the prevention of smallpox and monkeypox, the results of a matched case-control study conducted in 12 U.S. jurisdictions to evaluate the vaccine's effectiveness against monkeypox. |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder